Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Alger Health Sciences Fund

+ Add to Watchlist

AHSCX:US

20.05 USD 0.14 0.69%

As of 09:29:30 ET on 02/27/2015.

Snapshot for Alger Health Sciences Fund (AHSCX)

Year To Date: +7.62% 3-Month: +7.95% 3-Year: +22.19% 52-Week Range: 14.74 - 20.19
1-Month: +5.36% 1-Year: +19.74% 5-Year: +16.59% Beta vs SPX: 0.90

Mutual Fund Chart for AHSCX

No chart data available.
  • AHSCX:US 20.05
  • 1M
  • 1Y
Interactive AHSCX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for AHSCX

Alger Health Sciences Fund is an open-end fund incorporated in the USA. The Fund seeks long-term capital appreciation. The Fund invest in equity securities of companies of any market capitalization that are engaged in the health sciences sector.

Inception Date: 05-01-2002 Telephone: 1-800-992-3863
Managers: DANIEL C CHUNG "DAN" / TERESA MCROBERTS
Web Site: www.alger.com

Fundamentals for AHSCX

NAV (on 2015-02-27) 20.05
Assets (M) (on 2015-02-27) 210.98
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 50.00

Dividends for AHSCX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2014-12-18) 1.52
Dividend Yield (ttm) 27.11

Fees & Expenses for AHSCX

Front Load 0.00
Back Load 2.00
Current Mgmt Fee 0.81
Redemption Fee 2.00
12b1 Fee 1.00
Expense Ratio 2.10

Top Fund Holdings for AHSCX

Filing Date: 10/31/2014
Name Position Value % of Total
Gilead Sciences Inc 121,050 13,557,600 6.482%
Actavis plc 45,267 10,988,112 5.253%
HCA Holdings Inc 153,600 10,759,680 5.144%
Cigna Corp 72,950 7,263,632 3.473%
Celgene Corp 65,850 7,051,877 3.371%
Biogen Idec Inc 21,950 7,047,706 3.369%
UnitedHealth Group Inc 68,300 6,489,183 3.102%
AbbVie Inc 95,550 6,063,603 2.899%
Pharmacyclics Inc 44,250 5,782,148 2.764%
Zimmer Holdings Inc 48,200 5,361,768 2.563%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil